Skip to main content
SpringerLink
Log in

Association of the human bradykinin B2 receptor gene with chronic renal failure

  • Original Research Article
  • Published:
Molecular Diagnosis Aims and scope Submit manuscript

Abstract

Introduction: The kallikrein-kinin system plays an important role in blood pressure homeostasis and renal sodium regulation, and some studies have reported that the kinins have a protective effect against hypertension and the development of renal disease. The B2-bradykinin receptor (B2R) mediates the majority of physiological actions of bradykinin. We investigated the effect of the C181→T polymorphism in exon 2 of the B2R gene in patients with end-stage renal disease (ESRD).

Methods: This study involved 790 patients with ESRD and 510 healthy controls. All participants were genotyped for the B2R C181→T polymorphism by PCR followed by digestion of a PCR product with TaqI restriction endonuclease. DNA fragments were separated by agarose gel electrophoresis. Genotype and allele frequencies were compared between the groups. All calculations were performed using SPSS® 5.0 for Windows®.

Results: B2R genotype distribution in patients and controls was in accordance with Hardy-Weinberg equilibrium. The frequency of the T allele was higher in ESRD patients than in controls. The significant difference was observed in the age at onset of renal disease; for patients with the T allele the mean age at onset was 36.8 years, compared with 52.4 years for those carrying only the C allele (p < 0.001). The frequencies of the T allele and carrier genotypes were not associated with gender, presence of hypertension, or underlying kidney disease.

Conclusion: Our results suggest that the B2R polymorphism has a potential role in the earlier development of chronic renal failure in susceptible individuals. We did not confirm the previously published reports that the B2R gene polymorphism has a protective role in the development of ESRD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Freedman BI, Bowden DW. The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 1995 May; 4(3): 230–4

    Article  PubMed  CAS  Google Scholar 

  2. Freedman BI. Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 2003 Jul; 14 Suppl. 2: S192–4

    Article  PubMed  CAS  Google Scholar 

  3. Margolius HS. Kallikreins and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension 1998 Aug; 26(2): 221–9

    Article  Google Scholar 

  4. Schölkens BA. Kinins in the cardiovascular system. Immunopharmacology 1996 Jun; 33(1-3): 209–16

    Article  PubMed  Google Scholar 

  5. Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997 Jan; 29 (1 Pt 2): 488–93

    Article  PubMed  CAS  Google Scholar 

  6. Madeddu P, Milia AF, Salis MB, et al. Renovascular hypertension in bradykinin B2 receptor knockout mouse. Hypertension 1998 Sep; 32(3): 503–9

    Article  PubMed  CAS  Google Scholar 

  7. Hutchison FN, Martin VI. Effects of modulation of renal kallikrein-kinin system in the nephritic syndrome. Am J Physiol 1990 May; 258 (5 Pt 2): F1237–44

    Google Scholar 

  8. Uehara Y, Hirawa N, Numabe A. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Am J Hypertens 1997 May; 10 (5 Pt 2): S83–8

    Article  Google Scholar 

  9. Zychma MJ, Gumprecht J, Zukowska-Szczechowska E, et al. Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. J Am Soc Nephrol 1999 Oct; 10(10): 2120–4

    PubMed  CAS  Google Scholar 

  10. Prado GN, Taylor L, Zhou X, et al. Mechanisms regulating the expression, self maintenance and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 2002 Dec; 193(3): 275–86

    Article  PubMed  CAS  Google Scholar 

  11. Blaukat A. Structure and signaling pathways of kinin receptors. Andrologia 2003 Feb; 35(1): 17–23

    Article  PubMed  CAS  Google Scholar 

  12. Marceau F, Sabourin T, Houle S, et al. Kinin receptors: functional aspects. Int Immunopharmacol 2002 Dec; 2(13-14): 1729–39

    Article  PubMed  CAS  Google Scholar 

  13. Braun A, Kammerer S, Böhme E. Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Comm 1995 Jun; 211(1): 234–40

    Article  PubMed  CAS  Google Scholar 

  14. Braun A, Kammerer S, Maier E, et al. Polymorphisms in the gene for the human B2-bradykinin receptor: new tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 1996 Jun; 33(1–3): 32–5

    Article  PubMed  CAS  Google Scholar 

  15. Mukae S, Aoki S, Itoh S, et al. Promoter polymorphism of the B2-bradykinin receptor gene is associated with essential hypertension. Jpn Circ J 1999 Oct; 63(10): 759–62

    Article  PubMed  CAS  Google Scholar 

  16. Gainer JV, Brown NJ, Bachvarova M, et al. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans. Am J Hypertens 2000 Dec; 13(12): 1268–73

    Article  PubMed  CAS  Google Scholar 

  17. Wang B, Aiming D, Liu G. Genetic variation in the promoter region of the B2-bradykinin receptor gene is associated with essential hypertension in a Chinese Han population. Hypertens Res 2001 May; 24(3): 299–302

    Article  PubMed  CAS  Google Scholar 

  18. Mulatero P, Williams TA, Milan A, et al. Blood pressure in patients with primary aldosteronism is influenced by bradykinin B2 receptor and α-adducin gene polymorphisms. J Clin Endocrinol Metab 2002 Jul; 87(7): 3337–43

    Article  PubMed  CAS  Google Scholar 

  19. Erdmann J, Hegemann N, Weidemann A, et al. Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M). Am J Med Genet 1998 Dec; 80(5): 521–5

    Article  PubMed  CAS  Google Scholar 

  20. Dhamrait SS, Payne JR, Li P, et al. Variation in bradykinin receptor gene increases the cardiovascular risk associated with hypertension. Eur Heart J 2003 Sep; 24(18): 1672–80

    Article  PubMed  CAS  Google Scholar 

  21. Kusser B, Braun A, Praun M, et al. Polymorphisms in the bradykinin B2 receptor gene and childhood asthma. Biol Chem 2001 May; 382(5): 885–9

    Article  PubMed  CAS  Google Scholar 

  22. Bachvarov D, Landry M, Pelletier I, et al. Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure. J Am Soc Nephrol 1998 Apr; 9(4): 598–604

    PubMed  CAS  Google Scholar 

  23. Madisen L, Hoar LD, Holroyd CD, et al. DNA banking: the effects of storage of blood and isolated DNA on integrity of DNA. Am J Med Genet 1987 Jun; 27(2): 379–90

    Article  PubMed  CAS  Google Scholar 

  24. Abd Alla S, Quitterer U, Schroder C, et al. On the structure of the amino-terminal domain ED1 of the B2 receptor. Immunopharmacology 1996 Oct; 33(1): 42–5

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Skubiszewski Medical University of Lublin grants DS 233/03 and DS 235/03. The authors have provided no information on conflicts of interest directly relevant to the content of this study.

The authors wish to thank Ms Danuta Spasiewicz and Ms Teresa Mowicka for their technical assistance.

Author information

Authors and Affiliations

  1. Laboratory for Molecular Diagnostics of Multifactorial Diseases, Department of Nephrology, Skubiszewski Medical University, Dr K. Jaczewskiego 8, Lublin, 20-954, Poland

    Lucyna Jozwiak, Kinga Buraczynska, Piotr Ksiazek, Piotr Mierzicki &  Monika Buraczynska

  2. Department of Radiology, Skubiszewski Medical University, Lublin, Poland

    Andrzej Drop

Authors
  1. Lucyna Jozwiak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej Drop
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kinga Buraczynska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Piotr Ksiazek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piotr Mierzicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monika Buraczynska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Buraczynska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jozwiak, L., Drop, A., Buraczynska, K. et al. Association of the human bradykinin B2 receptor gene with chronic renal failure. CNS Drugs 8, 157–161 (2004). https://doi.org/10.1007/BF03260059

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03260059

Keywords

Search

Navigation